| Dr Susan L Mitchell, MD | |
|
1200 Centre St, Hebrew Rehabilitation Center For Aged, Roslindale, MA 02131 | |
| (617) 363-8626 | |
| (617) 363-8929 |
| Full Name | Dr Susan L Mitchell |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Location | 1200 Centre St, Roslindale, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205949617 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 80999 (Massachusetts) | Primary |
| Entity Name | Hebrew Seniorlife Affiliated Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1477069391 PECOS PAC ID: 2062774177 Enrollment ID: O20180328002953 |
News Archive
Hinchingbrooke Hospital in Cambridgeshire becomes the first NHS hospital to be run entirely by a private company called Circle. This new company is co-owned by its employees. The new administration has taken on the previous debt and it intends to make the hospital into one of the top ten in the country.
Thyroid cancer among people with lower socioeconomic status is diagnosed at a more advanced stage, according to new data presented at the 82nd Annual Meeting of the American Thyroid Association (ATA) in Québec City, Québec, Canada.
NuGEN Technologies, the provider of innovative RNA and DNA amplification and sample preparation technologies for breakthrough genomic analysis, today announced it has received the State of California cGMP (current Good Manufacturing Practices) certification following a rigorous audit process. NuGEN is one of the first sample preparation companies to receive this certification, which allows the company to manufacture and ship any of its products under cGMP compliance.
Researchers at the Stanford University School of Medicine have identified the cancer stem cells that propagate tumors in colon and rectal cancer, a discovery that could lead to improved treatment of this deadly cancer.
Radius Health ("Radius") announced today that the first patient has been dosed in the company's proof-of-concept Phase 2a study of RAD1901, an investigational selective estrogen receptor modulator (SERM) undergoing clinical evaluation for treatment of vasomotor symptoms (menopausal hot flashes).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Susan L Mitchell, MD 142 Hillcrest Road, Needham, MA 02492 Ph: (781) 455-6624 | Dr Susan L Mitchell, MD 1200 Centre St, Hebrew Rehabilitation Center For Aged, Roslindale, MA 02131 Ph: (617) 363-8626 |
News Archive
Hinchingbrooke Hospital in Cambridgeshire becomes the first NHS hospital to be run entirely by a private company called Circle. This new company is co-owned by its employees. The new administration has taken on the previous debt and it intends to make the hospital into one of the top ten in the country.
Thyroid cancer among people with lower socioeconomic status is diagnosed at a more advanced stage, according to new data presented at the 82nd Annual Meeting of the American Thyroid Association (ATA) in Québec City, Québec, Canada.
NuGEN Technologies, the provider of innovative RNA and DNA amplification and sample preparation technologies for breakthrough genomic analysis, today announced it has received the State of California cGMP (current Good Manufacturing Practices) certification following a rigorous audit process. NuGEN is one of the first sample preparation companies to receive this certification, which allows the company to manufacture and ship any of its products under cGMP compliance.
Researchers at the Stanford University School of Medicine have identified the cancer stem cells that propagate tumors in colon and rectal cancer, a discovery that could lead to improved treatment of this deadly cancer.
Radius Health ("Radius") announced today that the first patient has been dosed in the company's proof-of-concept Phase 2a study of RAD1901, an investigational selective estrogen receptor modulator (SERM) undergoing clinical evaluation for treatment of vasomotor symptoms (menopausal hot flashes).
› Verified 8 days ago
Sandra Shi, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Centre St, Roslindale, MA 02131 Phone: 617-971-5324 | |
Randi Ellen Berkowitz, Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1200 Centre St, Roslindale, MA 02131 Phone: 617-325-8000 | |
Alexandra Christodoulou, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1200 Centre St, Department Of Medicine, Roslindale, MA 02131 Phone: 617-363-8010 Fax: 617-363-8929 | |
Trimble S Augur, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Centre Street, Department Of Medicine, Roslindale, MA 02131 Phone: 617-363-8293 Fax: 617-363-8929 | |
Dr. David Wayne Chen, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 942 South St, Roslindale, MA 02131 Phone: 617-325-0520 Fax: 617-325-9047 | |
Dr. Hassan Arif, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Centre St, Roslindale, MA 02131 Phone: 617-363-8000 |